Related Experiment Video
Updated: May 24, 2026
08:42
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Polyunsaturated fatty acids and peripheral artery disease.
S Marlene Grenon1, Millie Hughes-Fulford, Joseph Rapp
1Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA 94121, USA. marlene.grenon@ucsfmedctr.org
Vascular Medicine (London, England)
|February 25, 2012
Summary
Polyunsaturated fatty acids (PUFAs) show promise in preventing atherosclerosis. This review focuses on the specific benefits of PUFAs for patients with peripheral artery disease (PAD), where evidence is currently limited.
Area of Science:
- Cardiovascular Science
- Nutritional Biochemistry
- Molecular Biology
Background:
- Polyunsaturated fatty acids (PUFAs), including n-3 and n-6 fatty acids (FAs), are recognized for their role in preventing atherosclerosis.
- In vitro and in vivo studies have elucidated the molecular mechanisms of FA interactions with monocytes and endothelial cells.
- Large clinical trials confirm n-3 FA supplementation reduces cardiovascular events in secondary prevention.
Purpose of the Study:
- To review the existing evidence on the efficacy of PUFAs in the context of peripheral artery disease (PAD).
- To identify gaps in knowledge regarding the specific benefits of n-3 and n-6 FAs for PAD patients.
Main Methods:
- Literature review of in vitro, in vivo, epidemiological, and randomized controlled trial studies.
- Focus on studies investigating monocyte-endothelial cell interactions and cardiovascular outcomes.
- Analysis of evidence specifically pertaining to patients diagnosed with peripheral artery disease.
Main Results:
- Substantial evidence supports the role of PUFAs in atherosclerosis prevention and cardiovascular event reduction.
- Data on the specific benefits of PUFAs in patients with peripheral artery disease (PAD) is limited and requires further investigation.
- Molecular mechanisms of FA action on cellular interactions are increasingly understood.
Conclusions:
- While n-3 FAs are beneficial for secondary cardiovascular prevention, their specific impact on PAD requires more research.
- Further studies are needed to establish clear guidelines for PUFA supplementation in peripheral artery disease management.
- Understanding the molecular effects of FAs on vascular cells remains crucial for cardiovascular health.
Related Concept Videos
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:26Peripheral Artery Disease IV: Nursing Management
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...